EndoSphere Inc. Announces Pivotal Financing led by Broadline Capital

EndoSphere Inc., a Central Ohio medical technology company and Ohio TechAngel portfolio company announced this week the completion of a highly oversubscribed Series A Preferred Financing round led by Broadline Capital, a global private equity investment firm.  EndoSphere is developing a platform of implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.  The company., which holds 23 U.S. and international issued and pending patents, will use the funding to expand its intellectual property assets and to complete additional clinical product testing. 

Broadline Capital’s co-investing partners in EndoSphere’s Series A Preferred Financing include investment firm Glengary LLC, Physician Investment Group LLC, and several of the nation’s largest angel investment funds including Ohio TechAngel Funds II and III, North Coast Angel Fund II, and QCA First Fund III.

For complete details, see the story on The Street.